Anderman Jonathan
SEC insider (Form 3/4/5 filer). CIK 0002032625. General Counsel at Compass Therapeutics, Inc. (CMPX). 5 reported Form 4/5 transactions since Sep 2024; latest on Apr 29, 2026. Located in BOSTON, MA.
Companies Anderman Jonathan has filed insider reports for
- Compass Therapeutics, Inc. (CMPX): Officer, General Counsel
Anderman Jonathan
CIK: 0002032625
Transaction Breakdown
Open Market Buys (P)2 (40.0%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)3 (60.0%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
CMPX
Compass Therapeutics, Inc.
Officer
Discretionary Trading P&L
Holdings
Transaction History (5 total)
- Apr 29, 2026CMPX
Compass Therapeutics, Inc.
PurchaseDirect25K shares at avg. $1.89$47K - Apr 29, 2026CMPX
Compass Therapeutics, Inc.
AwardDirect25K shares at avg. $1.89$47K - Jan 2, 2026CMPX
Compass Therapeutics, Inc.
AwardDirect150K shares at avg. $5.17$776K - Apr 7, 2025CMPX
Compass Therapeutics, Inc.
PurchaseDirect20K shares at avg. $1.54$31K - Feb 11, 2025CMPX
Compass Therapeutics, Inc.
AwardDirectStock Option (Right to Buy)
280K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Apr 29, 2026 | CMPX Compass Therapeutics, Inc. | Purchase | 25,000 | $1.89 | $47,250 | Direct |
| Apr 29, 2026 | CMPX Compass Therapeutics, Inc. | Award | 25,000 | $1.89 | $47,250 | Direct |
| Jan 2, 2026 | CMPX Compass Therapeutics, Inc. | Award | 150,000 | $5.17 | $775,500 | Direct |
| Apr 7, 2025 | CMPX Compass Therapeutics, Inc. | Purchase | 20,000 | $1.54 | $30,800 | Direct |
| Feb 11, 2025 | CMPX Compass Therapeutics, Inc. | Award Stock Option (Right to Buy) | 280,000 | - | - | Direct |
1-5 of 5 transactions